CVS Health revenue and financials

CVS · NYSE · USD

$85.76−1.44%−$1.25

Close · October 6, 2026

In the fiscal year ended December 2025, CVS Health reported revenue of $402.07B (+7.85% year over year). Net income was $1.77B, a net margin of 0.4%.

Annual revenue · 2025: $402.07B

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total revenue	402,067	372,809	357,776	322,467	292,111	268,706	256,776	194,579	184,786	177,546
Cost of revenue	221,167	206,287	217,098	196,892	175,803	163,981	158,719	156,447	156,220	148,669
Gross profit	53,129	49,248	53,278	53,664	50,921	—	—	—	28,545	28,857
Selling, general and administrative	43,110	41,229	39,205	37,922	36,764	—	—	—	—	—
Operating income	4,660	8,516	13,743	7,954	13,310	13,911	11,987	4,021	9,538	10,386
EBIT	10,019	8,019	14,073	15,742	14,157	—	—	—	—	—
EBITDA	14,625	12,616	18,439	19,966	18,643	—	—	—	—	—
Interest expense	3,119	2,958	2,658	2,287	2,503	2,907	3,035	2,619	1,062	1,078
Pre-tax income	2,136	6,148	11,173	5,836	10,537	—	—	—	—	—
Income tax	408	1,562	2,805	1,509	2,548	2,569	2,366	2,002	1,637	3,317
Net income	1,768	4,614	8,344	4,311	8,001	7,179	6,634	-594	6,622	5,317
Net income to common shareholders	1,768	4,614	8,344	4,311	8,001	—	—	—	—	—
Basic EPS	1.40	3.67	6.49	3.29	6.07	5.48	5.10	-0.57	6.47	4.93
Diluted EPS	1.39	3.66	6.47	3.26	6.02	5.46	5.08	-0.57	6.44	4.90
Average shares (basic)	1,267	1,259	1,285	1,312	1,319	—	—	—	—	—
Average shares (diluted)	1,271	1,262	1,290	1,323	1,329	1,314	1,305	1,044	1,024	1,079
Dividend per share	2.66	2.66	2.42	2.20	2.00	—	—	—	—	—